Vitamin D cell signalling in health and disease

被引:198
作者
Berridge, Michael J. [1 ]
机构
[1] Babraham Inst, Cambridge CB22 3AT, England
关键词
Vitamin D; Calcium; Reactive oxygen species; Alzheimer's disease; Parkinson's disease; Schizophrenia; CALCIUM-SENSING RECEPTOR; INOSITOL 1,4,5-TRISPHOSPHATE RECEPTORS; (1-42)-INDUCED OXIDATIVE STRESS; PROTEIN S-GLUTATHIONYLATION; COLON-CARCINOMA CELLS; ALZHEIMERS-DISEASE; 1,25-DIHYDROXYVITAMIN D-3; D DEFICIENCY; MULTIPLE-SCLEROSIS; 1-ALPHA; 25-DIHYDROXYVITAMIN D-3;
D O I
10.1016/j.bbrc.2015.01.008
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
070307 [化学生物学]; 071010 [生物化学与分子生物学];
摘要
Vitamin D deficiency has been linked to many human diseases such as Alzheimer's disease (AD), Parkinson's disease (PD), multiple sclerosis (MS), hypertension and cardiovascular disease. A Vitamin D phenotypic stability hypothesis, which is developed in this review, attempts to describe how this vital hormone acts to maintain healthy cellular functions. This role of Vitamin D as a guardian of phenotypic stability seems to depend on its ability to maintain the redox and Ca2+ signalling systems. It is argued that its primary action is to maintain the expression of those signalling components responsible for stabilizing the low resting state of these two signalling pathways. This phenotypic stability role is facilitated through the ability of vitamin D to increase the expression of both Nrf2 and the anti-ageing protein Klotho, which are also major regulators of Ca2+ and redox signalling. A decline in Vitamin D levels will lead to a decline in the stability of this regulatory signalling network and may account for why so many of the major diseases in man, which have been linked to vitamin D deficiency, are associated with a dysregulation in both ROS and Ca2+ signalling. (C) 2015 Elsevier Inc. All rights reserved.
引用
收藏
页码:53 / 71
页数:19
相关论文
共 345 条
[1]
Abraham CR, 2012, FUTURE MED CHEM, V4, P1671, DOI [10.4155/fmc.12.134, 10.4155/FMC.12.134]
[2]
ACHESON E. D., 1960, ACTA PSYCHIATR ET NEUROL SCAND SUPPL, V35, P132, DOI 10.1111/j.1600-0447.1960.tb08674.x
[3]
Update in Vitamin D [J].
Adams, John S. ;
Hewison, Martin .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2010, 95 (02) :471-478
[4]
Intervention in autoimmunity: The potential of vitamin D receptor agonists [J].
Adorini, L .
CELLULAR IMMUNOLOGY, 2005, 233 (02) :115-124
[5]
The Wnt antagonist DICKKOPF-1 gene is induced by 1α,25-dihydroxyvitamin D3 associated to the differentiation of human colon cancer cells [J].
Aguilera, Oscar ;
Pena, Cristina ;
Miguel Garcia, Jose ;
Jesus Larriba, Maria ;
Ordonez-Moran, Paloma ;
Navarro, Diego ;
Barbachano, Antonio ;
Lopez de Silanes, Isabel ;
Ballestar, Esteban ;
Fraga, Mario F. ;
Esteller, Manel ;
Gamallo, Carlos ;
Bonilla, Felix ;
Manuel Gonzalez-Sancho, Jose ;
Munoz, Alberto .
CARCINOGENESIS, 2007, 28 (09) :1877-1884
[6]
Peptidoglycan and lipopolysaccharide activate PLCγ2, leading to enhanced cytokine production in macrophages and dendritic cells [J].
Aki, Daisuke ;
Minoda, Yasumasa ;
Yoshida, Hideyuki ;
Watanabe, Satoko ;
Yoshida, Ryoko ;
Takaesu, Giichi ;
Chinen, Takatoshi ;
Inaba, Toshiya ;
Hikida, Masaki ;
Kurosaki, Tomohiro ;
Saeki, Kazuko ;
Yoshimura, Akihiko .
GENES TO CELLS, 2008, 13 (02) :199-208
[7]
Alexianu ME, 1998, J NEUROSCI RES, V51, P58, DOI 10.1002/(SICI)1097-4547(19980101)51:1<58::AID-JNR6>3.0.CO
[8]
2-K
[9]
ALROY I, 1995, MOL CELL BIOL, V15, P5789
[10]
Amtul Z, 2012, NEUROBIOL AGING, V33, DOI [10.1016/j.neurobiolaging.2011.07.014, 10.1016/j.neurobiolaging.2011.12.038]